 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
|
||
 |
|
||||||
sole application by StaGen |
|
| Patent No. | JP 2003-292537 (Japan) |
| Project Name | Osteoporosis caused by lack of movement |
| Title | Drug for the treatment or prevention of osteoporosis caused by lack of movement. |
| Abstract | Geranyl-geranyl-acetone or related compounds are safe and efficient drugs for the treatment and prevention of osteoporosis. |
| Working example | DNA chip etc. |
| Information | Nanke Y, Kotake S, Ninomiya T, Furuya T, Ozawa H, Kamatani N. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats. Calcif Tissue Int. 2005 Dec;77(6):376-85. |
|
|
|
|
 |
|
||
 |
 |
 |
|
 |
|
||
| Copyright © 2005-2008 StaGen Co., Ltd. All rights reserved. |